• FirefoxInstall the new Firefox »
  •  Dow Down 0.63% Nasdaq Down 0.24%

    Chimerix, Inc. (CMRX)

    -NasdaqGM
    40.83 Up 0.34(0.85%) 3:22PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:40.49
    Open:41.16
    Bid:40.51 x 100
    Ask:40.58 x 100
    1y Target Est:46.13
    Beta:1.017
    Next Earnings Date: 6-Mar-15CMRX Earnings announcement
    Day's Range:40.26 - 41.59
    52wk Range:14.02 - 43.41
    Volume:485,174
    Avg Vol (3m):450,465
    Market Cap:1.49B
    P/E (ttm):N/A
    EPS (ttm):-1.58
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CMRXUp 0.85%1.49B
    GNBTDown 1.69%N/A
    GILDUp 0.20%153.41B
    SIGAUp 3.43%128.94M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):392.47
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.76
    Quarterly EPS Est (Dec-14) :-0.48
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Chimerix, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel, oral antivirals to address unmet medical needs in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback